By 
The U.S. Food and Drug Administration may finally weigh in with potential food and food supplement guidelines on the use of legal cannabis-derived products in the coming months, some four years after hemp became legal under federal law, The Wall Street Journal reported Tuesday.
The FDA will decide within months on how legal cannabis and cannabis-derived cannabidiol (CBD) should be regulated, officials told the newspaper.
“I don’t think that we can have the perfect be the enemy of the good when we’re looking at such a vast market that is so available and utilized,” FDA adviser Norman Birenbaum said in the article. “You’ve got a widely unregulated market.”
The FDA’s effort comes after a death of a child in Virginia who had eaten gummies containing Delta-8, an ingredient made from hemp.
“The safety profiles around these products are not what they are generally accustomed to and not the same as what they get from other products when they walk into a wellness store or grocery store or even a gas station,” Birenbaum said.
Hemp was legalized in the annual Farm Bill back in 2018, but the FDA has not published any safety guideline or labeling requirements for CBD partly because cannabis remains a prohibited drug under federal law.
Also Read: FDA releases guidelines for cannabis-related research, but CBD will have to wait
Comments